CLINICAL_TRIALS
trial_result
· 2020-01-07
Clinical Trial Update: A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure [Phase 2]
Summary
Phase 2 study evaluating intravenous dose of aMBMC in subjects with non-ischemic heart failure has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CardioCell LLC | Conditions: Non-Ischemic Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2020-01-07